Items where authors include "Auchus, R.J."

Article

Fleseriu, M., Pivonello, R., Newell-Price, J. et al. (10 more authors) (2025) Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies. Pituitary, 28. 22. ISSN 1386-341X

Righi, B. orcid.org/0000-0003-4084-1077, Ali, S.R., Bryce, J. et al. (19 more authors) (2023) Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia. Endocrine, 80 (3). pp. 630-638. ISSN 1355-008X

Fleseriu, M., Newell-Price, J., Pivonello, R. et al. (12 more authors) (2022) Long-term outcomes of osilodrostat in Cushing’s disease: LINC 3 study extension. European Journal of Endocrinology, 187 (4). pp. 531-541. ISSN 0804-4643

Prete, A., Auchus, R.J. and Ross, R.J. orcid.org/0000-0001-9222-9678 (2022) Clinical advances in the pharmacotherapy of congenital adrenal hyperplasia. European Journal of Endocrinology, 186 (1). R1-R14. ISSN 0804-4643

Reisch, N., Taylor, A.E., Nogueira, E.F. et al. (8 more authors) (2019) Alternative pathway androgen biosynthesis and human fetal female virilization. Proceedings of the National Academy of Sciences, 116 (44). pp. 22294-22299. ISSN 0027-8424

Proceedings Paper

Fleseriu, M., Pivonello, R., Newell-Price, J. et al. (10 more authors) (2024) 6907 Continued improvements in hypertension and diabetes during long-term osilodrostat therapy in patients with Cushing’s disease: a pooled analysis from the phase III LINC 3 and LINC 4 studies. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .